Detalhe da pesquisa
1.
Archway Randomized Phase 3 Trial of the Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration.
Ophthalmology
; 129(3): 295-307, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34597713
2.
Patient Preference and Treatment Satisfaction With a Port Delivery System for Ranibizumab vs Intravitreal Injections in Patients With Neovascular Age-Related Macular Degeneration: A Randomized Clinical Trial.
JAMA Ophthalmol
; 140(8): 771-778, 2022 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35708706
3.
End-of-Study Results for the Ladder Phase 2 Trial of the Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration.
Ophthalmol Retina
; 5(8): 775-787, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33217618